Last updated on January 2020

A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis

Brief description of study

The purpose of this study is to evaluate the efficacy, safety, pharmacodynamic (PD) and pharmacokinetic (PK) effect of VX-561.

Clinical Study Identifier: NCT03911713

Find a site near you

Start Over

Mater Adult Hospital

South Brisbane, Australia
  Connect »